Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/29301
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWeimar C.en
dc.contributor.authorThijs V.en
dc.contributor.authorMassaro A.en
dc.contributor.authorLees K.R.en
dc.contributor.authorCadilhac D.A.en
dc.contributor.authorKim J.en
dc.contributor.authorWilson A.en
dc.contributor.authorBerge E.en
dc.contributor.authorPatel A.en
dc.contributor.authorAli M.en
dc.contributor.authorSaver J.en
dc.contributor.authorChristensen H.en
dc.contributor.authorCuche M.en
dc.contributor.authorCrews S.en
dc.contributor.authorWu O.en
dc.contributor.authorProvoyeur M.en
dc.contributor.authorMcMeekin P.en
dc.contributor.authorDurand-Zaleski I.en
dc.contributor.authorFord G.A.en
dc.contributor.authorMuhlemann N.en
dc.contributor.authorBath P.M.en
dc.contributor.authorRanta A.en
dc.contributor.authorAbdul-Rahim A.H.en
dc.contributor.authorSunnerhagen K.en
dc.contributor.authorMeretoja A.en
dc.date.accessioned2021-05-14T09:53:55Zen
dc.date.available2021-05-14T09:53:55Zen
dc.date.copyright2020en
dc.date.created20200629en
dc.date.issued2020-06-29en
dc.identifier.citationEuropean Stroke Journal. 5 (2) (pp 184-192), 2020. Date of Publication: 01 Jun 2020.en
dc.identifier.issn2396-9873en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/29301en
dc.description.abstractIntroduction: Approaches to economic evaluations of stroke therapies are varied and inconsistently described. An objective of the European Stroke Organisation (ESO) Health Economics Working Group is to standardise and improve the economic evaluations of interventions for stroke. Method(s): The ESO Health Economics Working Group and additional experts were contacted to develop a protocol and a guidance document for data collection for economic evaluations of stroke therapies. A modified Delphi approach, including a survey and consensus processes, was used to agree on content. We also asked the participants about resources that could be shared to improve economic evaluations of interventions for stroke. Result(s): Of 28 experts invited, 16 (57%) completed the initial survey, with representation from universities, government, and industry. More than half of the survey respondents endorsed 13 specific items to include in a standard resource use questionnaire. Preferred functional/quality of life outcome measures to use for economic evaluations were the modified Rankin Scale (14 respondents, 88%) and the EQ-5D instrument (11 respondents, 69%). Of the 12 respondents who had access to data used in economic evaluations, 10 (83%) indicated a willingness to share data. A protocol template and a guidance document for data collection were developed and are presented in this article. Conclusion(s): The protocol template and guidance document for data collection will support a more standardised and transparent approach for economic evaluations of stroke care.Copyright © European Stroke Organisation 2020.en
dc.languageenen
dc.languageEnglishen
dc.publisherSAGE Publications Ltd (E-mail: info@sagepub.co.uk)en
dc.relation.ispartofEuropean Stroke Journal-
dc.subject.meshtraining-
dc.subject.meshaphasia-
dc.subject.meshatrial fibrillation-
dc.subject.meshbrain ischemia-
dc.subject.meshcerebrovascular accident-
dc.subject.meshDelphi study-
dc.subject.meshdementia-
dc.subject.meshdrug cost-
dc.subject.mesheconomic development-
dc.subject.meshMAPK signaling-
dc.subject.meshmultiple sclerosis-
dc.subject.meshNational Institutes of Health Stroke Scale-
dc.subject.meshquality adjusted life year-
dc.subject.meshquality of life-
dc.subject.meshRankin scale-
dc.subject.meshsocial support-
dc.titleImproving economic evaluations in stroke: A report from the ESO Health Economics Working Group.en
dc.typeArticleen
dc.identifier.affiliationMonash University - School of Clinical Sciences at Monash Health-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1177/2396987319897466-
dc.publisher.placeUnited Kingdomen
dc.identifier.source2004160545en
dc.identifier.institution(Cadilhac, Kim) Stroke and Ageing Research, School of Clinical Sciences at Monash Health, Monash University, Australia (Cadilhac, Kim, Thijs) Stroke Division, the Florey Institute of Neuroscience and Mental Health, Australia (Wilson, Ali) Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (Berge) Department of Internal Medicine, Oslo University Hospital, Oslo, Norway (Patel) Anita Patel Health Economics Consulting Ltd, London, United Kingdom (Patel) Centre for Primary Care and Public Health, Queen Mary University of London, London, United Kingdom (Ali) Nursing, Midwifery and Allied Health Professions Research Unit, Glasgow Caledonian University, Glasgow, United Kingdom (Saver) Comprehensive Stroke Center, Department of Neurology, University of California, Los Angeles, CA, United States (Christensen) Bispebjerg Hospital and University of Copenhagen, Copenhagen, Denmark (Cuche) Medtronic International Trading Sarl, Tolochenaz, Switzerland (Crews) Penumbra, Inc, One Penumbra Place, Alameda, CA, United States (Wu) Health Economics and Health Technology Assessment Research Group, University of Glasgow, Glasgow, United Kingdom (Provoyeur) Penumbra GmbH, Berlin, Germany (McMeekin) Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom (Durand-Zaleski) Health Economics, Assistance Publique Hopitaux de Paris, Paris, France (Ford) University of Oxford, United Kingdom (Muhlemann) Nestle Health Science, Nestec S.A, Vevey, Switzerland (Bath) Stroke Trials Unit, University of Nottingham, Nottingham, United Kingdom (Abdul-Rahim) Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, United Kingdom (Sunnerhagen) Section of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden (Meretoja) Department of Medicine, University of Melbourne, VIC, Australia (Meretoja) Neurocenter, Helsinki University Hospital, Helsinki, Finland (Weimar) Department of Neurology, University Hospital Essen, Essen, Germany (Massaro) Department of Neurology, Hospital Sirio-Libanes, Sao Paulo, Brazil (Massaro) Neurovascular Research Unit, Brain Institute of Rio Grande do Sul (BraIns), PUCRS, Porto Alegre - RS, Brazil (Ranta) Department of Medicine, University of Otago, Wellington, New Zealand (Lees) School of Medicine, Dentistry Nursing, University of Glasgow, Glasgow, United Kingdomen
dc.description.addressD.A. Cadilhac, Stroke and Ageing Research, School of Clinical Sciences at Monash Health, Monash University, Australia. E-mail: dominique.cadilhac@monash.edu D.A. Cadilhac, Stroke Division, the Florey Institute of Neuroscience and Mental Health, Australia. E-mail: dominique.cadilhac@monash.eduen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2020 Elsevier B.V., All rights reserved.en
dc.subect.keywordseconomic evaluation EuroQol health outcomes health policy modified Rankin Scale Strokeen
dc.identifier.authoremailCadilhac D.A.; dominique.cadilhac@monash.eduen
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeArticle-
Appears in Collections:Articles
Show simple item record

Page view(s)

44
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.